chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 2 hours after receiving the vaccines, developed a headache, shaking, and fever to 102.5.  Fever came down by the evening.
The Pharmacist wrote an expiration date of 24-Mar-2022 on the Moderna Covid-19 vaccine instead of 24-Feb-2022; Pharmacy gave Moderna COVID-19 vaccine past its beyond use date to 21 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Pharmacy gave Moderna COVID-19 vaccine past its beyond use date to 21 patients) and PRODUCT STORAGE ERROR (The Pharmacist wrote an expiration date of 24-Mar-2022 on the Moderna Covid-19 vaccine instead of 24-Feb-2022) in a 50-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 030H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Pharmacy gave Moderna COVID-19 vaccine past its beyond use date to 21 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The Pharmacist wrote an expiration date of 24-Mar-2022 on the Moderna Covid-19 vaccine instead of 24-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Pharmacy gave Moderna COVID-19 vaccine past its beyond use date to 21 patients) and PRODUCT STORAGE ERROR (The Pharmacist wrote an expiration date of 24-Mar-2022 on the Moderna Covid-19 vaccine instead of 24-Feb-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  On 24-Jan-2022, vial was transferred from the Freezer to the Refrigerator and initially stored in it. The vial did not undergo temperature excursion.  No information on treatment medication was reported.
Patient stated that she experienced a rash across her chest, face (specifically around her mouth and cheeks), as well as on both hands and around her knuckles within 24 hours of receiving the vaccination. Patients rash has since subsided.
Chest pain developed later on the same day as his 2nd Moderna COVID-19 vaccine dose. He presented to the emergency department on 6/27/21. Other symptoms, including body aches, headaches, and fatigue resolved prior to presentation. The chest pain resolved completely by 6/28/21, the day after presentation. He was given ibuprofen for pain management. He was monitored on telemetry without significant events as of the time of this report. He was being treated for a presumed diagnosis of myocarditis secondary to the Moderna COVID-19 vaccine.
PATIENTS' HUSBAND REPORTED THAT PATIENT DEVELOPED A RED RAISED RASH THE DAY AFTER INJECTION. STARTED OUT THE EVENING OF 3-18-19 AT THE INJECTION SITE THE SIZE OF A QUARTER AND GREW TO A RED RAISED RASH 3" BY 5" BY THE FOLLOWING DAY. PATIENT ALSO REPORTED PAIN AT THE INJECTION SITE. BY 3-24-19 THE RASH WAS SUBSIDING AND GETTING BETTER. THE PATIENT SAW AN URGENT CARE PHYSICIAN FOR AN UNRELATED MATTER AND HAD THE URGENT CARE PHYSICIAN LOOK AT RASH. THE URGENT CARE PHYSICIAN DID NOT PRESCRIBE ANY TREATMENT FOR THE RASH ACCORDING TO THE PATIENT.
Immunized 1/17/12 at pharmacy. 9 days later rash appeared near injection site, went all way down arms & back of neck. Doesn't itch. Seems to be getting worse. Dr recommended P.O. BENADRYL & lotion but not helping.
Pt. felt nauseous immediately and rested head against wall was semi unconscious. Pt. was laid on ground w/ feet up. EMS was called.
Patient called 1-3-22 to report she was experiencing a rapid heart rate of 120-130 for about 5 hours at that point. Patient takes labetolol for blood pressure and states no history of arrhythmia. She had an invitrofertilization procedure last week on 12/24/2021.   I spoke with patient again at 12:45pm 1-3-22. She said heart rate was now in the 107-113 range
Swollen lymph nodes above clavicle; Redness over those lymph nodes; Redness, pain, warmth, and swelling at injection site; Redness, pain, warmth, and swelling at injection site; Redness, pain, warmth, and swelling at injection site; Redness, pain, warmth, and swelling at injection site; This is a spontaneous report from a contactable other health professional (HCP). A 22-year-old non-pregnant female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248), via an unspecified route of administration on her left arm on 11Jan2021 at 07:45, at a single dose for COVID-19 immunisation. Medical history included allergies to sulfa. Concomitant medications included doxycycline and vitamin D3. The patient received her first dose of BNT162B2, lot number: EL0140 on 20Dec2020 at 02:30 PM. The patient experienced swollen lymph nodes above clavicle, redness over those lymph nodes, redness, pain, warmth, and swelling at injection site on 11Jan2021 at 18:30. There was no treatment received for the adverse events. The outcome of the events was recovering.
Could not feel her feet; Severe autoimmune reaction; Extraordinary burning on both of her feet; Nerve damaged on her feet,Nerve damaged travelled to calf; Raised lump at injection site; Itchy injection site; Red injection site; Sore injection arm; A spontaneous report was received from a consumer concerning a female patient of 65 years old, who received Moderna's COVID-19 vaccine(mRNA-1273) and experienced event(s) Sore injection arm, injection site redness, Raised lump at injection site, Itchy injection site, Severe autoimmune reaction, Extraordinary burning on both of her feet, Nerve damaged on her feet to calf, Could not feel her feet.  The patients medical history was not provided.No relevant Concomitant medications were reported.  On 14 Jan 2021,prior to the onset of events, the Patient received their first of two planned dose of mRNA-1273(batch number: 011L20A) vaccine intramuscularly in the upper left arm for prophylaxis of COVID-19 infection.  On 14 Jan 2021,later the day of vaccination, the injection arm became sore, the injection site had a red, itchy and raised lump. These symptoms progressed for some days.   On 24 Jan 2021, she started experiencing a severe autoimmune reaction, she had extraordinary burning on both of her feet. She took Tylenol and Benadryl hoping it will help alleviate the symptoms but the morning she could not feel her feet, her nerves were significantly damaged. The symptoms travelled to her calf. She has no previous autoimmune or health issues. the event severe autoimmune disorder was also considered to be medically significant. Her doctors has instructed her not to get the 2nd dose due to her side effects.   Treatment for the event included Tylenol and Benadryl.  Action taken with the mRNA-1273 in response to the event was not provided.  the outcome of the event(s) Sore injection arm, injection site redness, Raised lump at injection site, Itchy injection site, Severe autoimmune reaction, Extraordinary burning on both of her feet, Nerve damaged on her feet to calf and Could not feel her feet were unknown.; Reporter's Comments: Based on the current available information which includes a temporal association between the use of the product onset of the event and excluding any other etiology, a causal relationship with the event cannot be excluded.  Injection arm became sore, the injection site had a red, itchy and raised lump are consistent with the product safety profile.
mentioned he had his first shot on 31Jan2021 and missed his second dose because he was not feeling well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 31Jan2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "mentioned he had his first shot on 31Jan2021 and missed his second dose because he was not feeling well".  Additional Information: Patient mentioned he had his first shot on 31Jan2021 and missed his second dose because he was not feeling well. Patient would like to know if it was okay for him to take the second dose past 21 days.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Large area looks bruised around injection site. "Knob" near center. Started shortly after getting shot - stayed the same for a while then last couple of days seems to be spreading more.
pt had inconsolable crying for about 4 hrs following DTP/OPV/HIB immun; pt was fine the next day;
Patient receive a dose of the Pfizer vaccine and one dose of Moderna Covid-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Patient receive a dose of the Pfizer vaccine and one dose of Moderna Covid-19 vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient receive a dose of the Pfizer vaccine and one dose of Moderna Covid-19 vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Patient receive a dose of the Pfizer vaccine and one dose of Moderna Covid-19 vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that Patient took Pfizer vaccine in Feb 2021 but did not inform Pharmacist  No concomitant details were provided No treatment details were provided
Moderna COVID-19 Vaccine EUA  Fever, chills, severe headache, loss of appetite, all lasting 36 hours and then recurring again 12 hours later, lasting another 8 hours
Covid19 breakthrough.  1st vaccine received on 04/23/2021.  2nd vaccine on 05/14/2021 and 3rd vaccine on 01/26/2022.  75 y/o male with PMHx of HTN, Gout, CAD, AFib, Hypothyroidism, Pituitary adenoma s/p craniotomy 3/5/2022 and adrenal insufficiency presents to ED with 1 day history of dizziness, nausea, cough, congestion, weakness and fevers.  Temp 101.6, room air sat 96% and CXR with no acute findings.  Pt did require O2 at 2L NC for a time.  Treated with IV ABX, steroids and Remdesivir.
The day after the vaccine, I had extremely sore shoulders and arm muscles and could not raise my arms above my shoulders. I also had swollen glands in the neck and jaw. One week after the vaccine, on March 10, and again on March 13, I had severe vertigo and headache, (nausea and vomiting on March 13)  Vertigo has lasted intermittently for the past 17 days. My symptoms are now improving after vestibular PT and a doctor visit, and a course of valium. I have never had such  a severe episode and never one that has lasted this long.
Began to experience tachycardia in August 2021 after the first dose of the Pfizer COVID vaccine. I received the second dose in October 2021. In about May of 2022 I began to experience unusually high heart rates. I was diagnosed with POTS syndrome in May 2022. I never had this issue before until I received the COVID vaccine. I was prescribed Corlanor (expensive mediation) to keep my heart rate down and not effect my blood pressure which I am still taking to date.
Atherosclerotic Cardiovascular Disease complicated by Pulmonary Microvascular Thrombosis
Localized erythema, edema and tenderness at injection site; developed within 10-12 hours of injection. Has continued for 36 hours.
2 weeks, post exposure to chickenpox, he ran a low-grade fever, broke out with "only a few small, red bumps with small head to them".
Achy all over; Soreness at the injection site; Rash at the injection site; Every bone in her body hurt; Unable to sleep; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Every bone in her body hurt), INSOMNIA (Unable to sleep), PAIN (Achy all over), INJECTION SITE PAIN (Soreness at the injection site) and INJECTION SITE RASH (Rash at the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced BONE PAIN (Every bone in her body hurt), INSOMNIA (Unable to sleep), INJECTION SITE PAIN (Soreness at the injection site) and INJECTION SITE RASH (Rash at the injection site). On 29-Mar-2021, the patient experienced PAIN (Achy all over). At the time of the report, BONE PAIN (Every bone in her body hurt), INSOMNIA (Unable to sleep), PAIN (Achy all over), INJECTION SITE PAIN (Soreness at the injection site) and INJECTION SITE RASH (Rash at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  Tylenol was taken as treatment medication.   This case was linked to MOD-2021-060108 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Followup received: Treatment medication and events outcome added
PATIENT COMPLAINED OF FLU-LIKE SYMPTOMS (BODY ACHES, FEVER, CHILLS,  AND FATIGUE) THAT STARTED THE EVENING HE RECEIVED THE VACCINE AND LASTED FOR 3 DAYS. HE TOOK SOME IBUPROFEN AND IT HELPED THE PAIN A LITTLE.
Difficulty breathing, fever, muscle aches, headache, swelling of injection lower arm and hand, high blood pressure, loss of appetite, weight loss, fatigue.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. There was no information on pertinent medical history and drug reactions or allergies. On 07-SEP-2014, the patient was vaccinated with expired dose of PNEUMOVAX 23 INJ N/A 10 vials of 1 (Product Lot # J009827, Expiry date: 10-AUG-2014) dose .5 ml (millilitre), intramuscularly. The pharmacist reported that expired dose of PNEUMOVAX 23 was inadvertently administrated to patient. No adverse effects reported. There was no product quality complaint involved. The outcome of the event was unknown. Additional information has been requested.
Patient had a fever, was very lethargic, fatigued, started head jerking movements which happened several times a day for two weeks, and occasionally she will have the head jerk movements now three months later.  Patient broke out in a rash all over her body.
pt presented at pharmacy today with redness swelling and tenderness at the injection site and around injection site area
Pt became very pale, lethargic & unresponsive to stimuli x/pain stimuli; reaction lasted about 1/2 hr p/which pt remained lethargic but more reactive;
pt presented for 2nd covid vaccine without vaccine card, reported hx of Pfizer vaccination.  Later presented to have card filled out and noted hx of moderna-1st dose, Pfizer-2nd dose.  reports feeling well, no adverse reactions per patient on 6/9/21
testing positive for covid; 24 hour amnesia; This is a spontaneous report from a Pfizer-sponsored program. A contactable nurse reported that a 68-year-old female patient (reporter's mother) received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on 11Mar2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported the patient had an accidental finding of COVID positive on 19Mar2021. She had blood work when she had an overnight stay at the hospital but everything was fine. The patient was completely asymptomatic other than that. It was also reported that the patient ended up having 24 hour amnesia (as reported) on an unspecified date in Mar2021. During the day of the report, 01Apr2021, the patient was due for her second shot but was not allowed to get her second shot that day and that she needed to wait at least a month. The reporter wanted to know if this was correct. The patient did not receive treatment for the events. The outcome of the events was unknown.   Information on the lot/ batch number has been requested.; Sender's Comments: Based on the timing of finding a Covid positive test relative to day of vaccination, event 'Covid-19' was an intercurrent medical condition assessed not related to vaccination with BNT162B2.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Dose 1: stuffy nose, sore throat, sensitive to light and noise, overstimulation to any stressor, limited focus, whooshing in ears, inability to perform any tasks, brain fog. Lasted 4 days approx  Dose 2: mild whole body soreness for about a day. Developed heart palpitations that were consistent for about a month until I started taking coQ10
Case number PHEH2014US020336 is an initial spontaneous report received from a pharmacist on 07 OCT 2014 with the follow-up received on 14 OCT 2014. This report refers to a 65 year old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN 2014/2015 (batch number: 146401) intramuscularly at a dose of 0.5 ml on 06 OCT 2014. It was reported that before vaccination, the FLUVIRIN prefilled syringe reached 35.54 degree Fahrenheit for 1.5 hours. It was further reported that the total excursion was 1.5 hours and the vaccine was administered within the total duration. No adverse event was reported following this administration error (incorrect storage of drug).   Follow-up received on 14 OCT 2014:  Narrative updated with total excursion time and vaccination time (total excursion was 1.5 hours and the vaccine was administered within that total duration).
Exanthema, Pruritus-  Information has been received from a physician concerning a 16 year old male who on 18 May 2000 was vaccinated sc with one dose of varicella virus vaccine live (lot 632716/1690J) (Site unknown.  On 20 May 2000 the patient developed a generalized pruritic rash described as varicella like.  The patient sought unspecified medical attention and the physician noted erythematomus to dull pink discrete lesions scattered along the axis of the body following the linee of cleavage in a christmas tree distrubution.  They are most prominent on the trunk.  There is some fine scaling in the center of many  of the lesions which are oval shaped.  He had some very mild comedonal acen about the temples and forehead.  There are no vesicular lesions and no scabbed over vesicles.  On approximately 07 Jun 2000 the patient recovered.  No futher information is available.
Per patient's mother, child developed a fine rash within 24 hours of vaccination. Patient still has rash today. Rash is "fine" "very itchy" and extends from clavicle to hip bone with more rash on the anterior. No other symptoms. She was evaluated by her pediatrician. 11/23/09 for infectious cause. Mother states rash is not hives.
numbness/tingling in R arm, intermittent  not constant last 2-3 weeks prior to 2nd administration
Red Rash that is warm touch and some minor arm swelling lasting 48 hours so far. Pt is now using BENADRYL, APAP, and cold compresses to relieve symptoms.
admitted on 5/10/2021 for ASEPTIC NECROSIS OF BILAT FINGERS.  Following admission, the patient who has history of severe alcoholism and polysubstance abuse history, ADHD, smoker/ Vaping, on oral contraceptive, who had presented to the hospital with cyanosis of the tips of her fingers. Patient was diagnosis with dry gangrene of tips of fingers and evidence of bilateral upper extremities DVT. Patient was evaluated by vascular surgery, hematology, plastic surgery and Psychiatry . Patient was evaluated with echocardiogram and doppler of extremity. She was treated with calcium channel blocker, nitroglycerin paste and Botox injection to improve the blood flow to the extremity. The area of necrosis was stabilized. Patient was released home on 3 months of anticoagulation
Pt. received vaccine 4/24/15. 4/28 was reported to have developed tine papular rash on chin/perioral area. Was prescribed BENADRYL cream 1% for itch.
Per Dr. - Patient had syncopal event after GARDASIL approx. 15 minutes later. No injury recovered within 5 min.
After receiving the 6th dose I was diagnosed with Clear Cell Kidney Cancer again on 04/25/2023. On 10/21/2022 for the first time I was diagnosed with this cancer and I had 2 surgeries as well. After the 6th dose the doctor informed me that the cancer had returned. They did PET-SCAN and X-RAY where it was revealed with cancer. I had a surgery for my hip on 05/01/2023 I am recovering from it now. I have more appointments coming soon. I am still under treatments as of now and I haven't recovered yet.
Patient reported about 2 weeks ago she noticed that on her left arm down to her fingers it's a numb feeling; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Patient reported about 2 weeks ago she noticed that on her left arm down to her fingers it's a numb feeling) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No medical history were reported.  Concomitant products included METFORMIN, LISINOPRIL, LOSARTAN, CARVEDILOL, APIXABAN (ELIQUIS), OMEPRAZOLE and POTASSIUM for an unknown indication.    On 03-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced HYPOAESTHESIA (Patient reported about 2 weeks ago she noticed that on her left arm down to her fingers it's a numb feeling). At the time of the report, HYPOAESTHESIA (Patient reported about 2 weeks ago she noticed that on her left arm down to her fingers it's a numb feeling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications reported.
I had a discoloration on my left breast and slight pain underneath my left arm. I had NO  redness, NO swelling  and NO  heat underneath my arm.  I had a mammogram and the radiologist asked for an ultrasound.  The ultrasound revealed a deep vein thrombosis underneath my left arm.
This spontaneous case reported by a patient family member or friend, describes the occurrence of vaccination site reaction (magnet sticks to arm at vaccination site) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; unknown. On an unknown date, patient experienced vaccination site reaction (magnet sticks to arm at vaccination site). At the time of the report, vaccination site reaction (magnet sticks to arm at vaccination site) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant product use and treatment information not provided. Reporter did not allow further contact.